$PZG
Paramount Gold Nevada Corp

2021 Form 10-K Financial Statement

#000156459021048261 Filed on September 17, 2021

View on sec.gov

Income Statement

Concept 2021 2020 Q2 2020
Revenue $330.3K $0.00 $728.9K
YoY Change -54.69% -100.0% 82.05%
Cost Of Revenue $540.4K $191.6K $593.0K
YoY Change -8.87% 12.36% -2.79%
Gross Profit -$210.1K -$191.6K $135.9K
YoY Change -254.59% 14.96% -164.84%
Gross Profit Margin -63.63% 18.65%
Selling, General & Admin $2.410M $396.3K $1.728M
YoY Change 39.47% -18.83% -6.46%
% of Gross Profit 1271.39%
Research & Development $2.817M $865.9K $4.201M
YoY Change -32.95% -43.73% 18.05%
% of Gross Profit 3090.66%
Depreciation & Amortization $2.508K $460.00 $2.555K
YoY Change -1.84% -29.23% -2.48%
% of Gross Profit 1.88%
Operating Expenses $5.290M $1.286M $6.026M
YoY Change -12.23% -38.84% 5.63%
Operating Profit -$5.500M -$1.478M -$5.891M
YoY Change -6.64% -35.81% -0.41%
Interest Expense -$439.9K -$120.7K -$372.7K
YoY Change 18.04% 2363.47% -2205.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.904M -$1.641M -$6.430M
YoY Change -8.19% -28.89% 7.71%
Income Tax
% Of Pretax Income
Net Earnings -$5.904M -$1.641M -$6.430M
YoY Change -8.19% -28.89% 7.71%
Net Earnings / Revenue -1787.57% -882.16%
Basic Earnings Per Share $0.17 $0.23
Diluted Earnings Per Share $0.17 -$58.88K $0.23
COMMON SHARES
Basic Shares Outstanding 35.53M 27.58M
Diluted Shares Outstanding 35.53M 27.58M

Balance Sheet

Concept 2021 2020 Q2 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.113M $5.434M $5.434M
YoY Change -42.71% 1071.92% 1071.92%
Cash & Equivalents $3.113M $5.434M $5.434M
Short-Term Investments
Other Short-Term Assets $1.152M $442.6K $442.6K
YoY Change 160.37% 26.9% 26.9%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.265M $5.877M $5.877M
YoY Change -27.42% 623.32% 623.32%
LONG-TERM ASSETS
Property, Plant & Equipment $49.20M $47.34M $47.34M
YoY Change 3.93% 750999.16% 0.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $533.7K $695.0K $695.0K
YoY Change -23.21% -50.42% -50.42%
Total Long-Term Assets $49.74M $48.04M $48.04M
YoY Change 3.54% -0.88% -0.88%
TOTAL ASSETS
Total Short-Term Assets $4.265M $5.877M $5.877M
Total Long-Term Assets $49.74M $48.04M $48.04M
Total Assets $54.00M $53.91M $53.91M
YoY Change 0.17% 9.41% 9.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $639.0K $925.3K $925.3K
YoY Change -30.94% -5.62% -5.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $949.0K $1.079M $1.079M
YoY Change -12.09% 0.18% 0.18%
LONG-TERM LIABILITIES
Long-Term Debt $4.162M $5.292M $5.292M
YoY Change -21.36%
Other Long-Term Liabilities $1.540M $460.9K $460.9K
YoY Change 234.02% -46.92% -46.92%
Total Long-Term Liabilities $5.701M $5.753M $5.753M
YoY Change -0.9% 562.47% 562.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $949.0K $1.079M $1.079M
Total Long-Term Liabilities $5.701M $5.753M $5.753M
Total Liabilities $6.650M $6.832M $6.832M
YoY Change -2.67% 251.1% 251.1%
SHAREHOLDERS EQUITY
Retained Earnings -$54.13M
YoY Change 13.48%
Common Stock $101.2M
YoY Change 6.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.35M $47.08M $47.08M
YoY Change
Total Liabilities & Shareholders Equity $54.00M $53.91M $53.91M
YoY Change 0.17% 9.41% 9.41%

Cashflow Statement

Concept 2021 2020 Q2 2020
OPERATING ACTIVITIES
Net Income -$5.904M -$1.641M -$6.430M
YoY Change -8.19% -28.89% 7.71%
Depreciation, Depletion And Amortization $2.508K $460.00 $2.555K
YoY Change -1.84% -29.23% -2.48%
Cash From Operating Activities -$5.956M -$898.8K -$5.145M
YoY Change 15.76% -50.78% -8.67%
INVESTING ACTIVITIES
Capital Expenditures -$87.50K $0.00 -$4.720K
YoY Change 1753.81%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$87.50K $0.00 -$4.719K
YoY Change 1754.21% -100.0% -100.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.723M $4.883M
YoY Change -23.76% 67.73%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.723M 4.919M 10.12M
YoY Change -63.22% 161.36%
NET CHANGE
Cash From Operating Activities -5.956M -898.8K -5.145M
Cash From Investing Activities -87.50K 0.000 -4.719K
Cash From Financing Activities 3.723M 4.919M 10.12M
Net Change In Cash -2.321M 4.020M 4.970M
YoY Change -146.7% 3852.19% 2888.79%
FREE CASH FLOW
Cash From Operating Activities -$5.956M -$898.8K -$5.145M
Capital Expenditures -$87.50K $0.00 -$4.720K
Free Cash Flow -$5.869M -$898.8K -$5.141M
YoY Change 14.16% -50.78% -8.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38154109
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1152396
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
442596
CY2021Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
4161502
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
5256228
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
35628
CY2021Q2 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
1539622
CY2020Q2 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
460939
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5701124
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5752795
CY2021Q2 us-gaap Liabilities
Liabilities
6650096
CY2020Q2 us-gaap Liabilities
Liabilities
6832286
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
381542
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
329584
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
107005135
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
100881957
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60033947
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54130329
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
47352730
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
47081212
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54002826
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53913498
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020 us-gaap Revenues
Revenues
728910
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32958404
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38154109
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32958404
CY2021 us-gaap Other Income
OtherIncome
330259
CY2021 us-gaap Professional Fees
ProfessionalFees
174039
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1373451
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
989602
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
158694
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
92054
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
483608
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
495628
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
220480
CY2020 us-gaap General Insurance Expense
GeneralInsuranceExpense
150911
CY2021 us-gaap Depreciation
Depreciation
2508
CY2020 us-gaap Depreciation
Depreciation
2555
CY2020 us-gaap Other Income
OtherIncome
728910
CY2021 pzg Gain Loss On Forgiveness Of Promissory Note
GainLossOnForgivenessOfPromissoryNote
35947
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5903618
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6430141
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5903618
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35533269
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27583566
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35533269
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27583566
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
47329742
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
203192
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
976144
CY2020 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
119309
CY2020 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
4882966
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
436777
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
277941
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1157629
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
181458
CY2021 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
398777
CY2021 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
3722554
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
181458
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
976144
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
436777
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
203192
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
62903
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
54421
CY2021 pzg Interest Expense Income
InterestExpenseIncome
359253
CY2020 pzg Interest Expense Income
InterestExpenseIncome
324160
CY2021 pzg Gain Upon Forgiveness Of Promissory Note
GainUponForgivenessOfPromissoryNote
35947
CY2021 pzg Increase Decrease In Reclamaton Bonds And Accounts
IncreaseDecreaseInReclamatonBondsAndAccounts
163178
CY2020 pzg Increase Decrease In Reclamaton Bonds And Accounts
IncreaseDecreaseInReclamatonBondsAndAccounts
16487
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-246467
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-259901
CY2020 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4719
CY2021 pzg Payment To Acquire Mineral Properties
PaymentToAcquireMineralProperties
87500
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87500
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4719
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3722554
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4882966
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5201807
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
35628
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3722554
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10120401
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2321017
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4970391
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5434081
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
463690
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3113064
CY2019Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
161217
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
340660
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
690000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
66668
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
20000
CY2021Q2 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
2810000
CY2020Q2 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
5130000
CY2021 pzg Cash Uninsured Amount Description
CashUninsuredAmountDescription
The Company deposits its cash with financial institutions which it believes have sufficient credit quality to minimize the risk of loss
CY2021Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Net
EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
0
CY2020Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Net
EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
0
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
943992
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
755000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
664994
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1033998
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.79
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.38
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.74
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.74
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.51
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.56
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.50
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.55
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
143998
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
153802
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P9M10D
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y18D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
332835
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
202121
CY2021 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.0989
CY2020 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.0976
CY2021 pzg Weighted Average Inflation Rate
WeightedAverageInflationRate
0.0231
CY2020 pzg Weighted Average Inflation Rate
WeightedAverageInflationRate
0.0160
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
615170
CY2019Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
965677
CY2021 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
1498950
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
278181
CY2021 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
324516
CY2020 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
723279
CY2021Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1849644
CY2021 us-gaap Insurance Recoveries
InsuranceRecoveries
324516
CY2020 us-gaap Insurance Recoveries
InsuranceRecoveries
723279
CY2021 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5743
CY2020 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5631
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1239760
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1350330
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
157
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2426
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
1196349
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-57853
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
43254
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1405757
CY2021 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2019 2020 2021

Files In Submission

Name View Source Status
0001564590-21-048261-index-headers.html Edgar Link pending
0001564590-21-048261-index.html Edgar Link pending
0001564590-21-048261.txt Edgar Link pending
0001564590-21-048261-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gerxzw0zq02g000001.jpg Edgar Link pending
gerxzw0zq02g000002.jpg Edgar Link pending
gyamngfr2q2q000001.jpg Edgar Link pending
gyamngfr2q2q000002.jpg Edgar Link pending
gyamngfr2q2q000003.jpg Edgar Link pending
gyamngfr2q2q000004.jpg Edgar Link pending
gyamngfr2q2q000005.jpg Edgar Link pending
gyamngfr2q2q000006.jpg Edgar Link pending
gyamngfr2q2q000007.jpg Edgar Link pending
pzg-10k_20210630.htm Edgar Link pending
pzg-20210630.xml Edgar Link completed
pzg-20210630.xsd Edgar Link pending
pzg-20210630_cal.xml Edgar Link unprocessable
pzg-20210630_def.xml Edgar Link unprocessable
pzg-20210630_lab.xml Edgar Link unprocessable
pzg-20210630_pre.xml Edgar Link unprocessable
pzg-ex211_11.htm Edgar Link pending
pzg-ex231_12.htm Edgar Link pending
pzg-ex311_9.htm Edgar Link pending
pzg-ex312_10.htm Edgar Link pending
pzg-ex321_7.htm Edgar Link pending
pzg-ex322_8.htm Edgar Link pending
pzg-ex41_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending